Chronic hepatitis C. Chronic viral hepatitis C
Conditions
Interventions
Intervention 1: Intervention group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally daily and camel milk 250
Treatment - Drugs
Intervention group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally daily and camel milk 250 cc daily in the
Control group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally for three months.
Sponsors
Mashhad University of Medical Sciences ,Vice chancellor for research
Razi vaccine and Serum research Institue of Mashhd
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: age 18 to 70 years? the detection of serum HCV RNA by PCR. exclusion criteria:Decompensated cirrhosis; autoimmune diseases; cancer; infected with HIVorHBV;neutropenia;thrombocytopenia; creatinine higher;organ transplant;severe heart disease; chronic lung disease; uncontrolled psychiatric illness; epilepsy; diabetic retinopathy; active alcohol or addiction; pregnancy;anemia;non-compliance with the prescribed dosage milk; discourage patients from continuing to participate in the plan; other genotypesto participate in the plan; other genotypes
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantification of HCV RNA. Timepoint: One Month. Method of measurement: PCR.;Level of ALT,AST. Timepoint: One Month. Method of measurement: unit /ml. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Noras
Faculty of Traditional Medicine
Outcome results
None listed